Pfizer Inc revealed that the US Food and Drug Administration (FDA) has authorized BRAFTOVI (encorafenib) alongside cetuximab (sold as ERBITUX) and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) for treating patients with metastatic...
In the financial year 2024, India's pharmaceutical exports totaled Rs 2.3 lakh crore, an increase from Rs 1.1 lakh crore in FY14. Pharma exports increased by 8.36% from Rs 17,750 crore in July 2023 to Rs 18,670 crore in July 2024. The government...
The pharmaceutical sector in India ranks among the leading industries drawing investments. India's healthcare and pharmaceutical industries secured Rs 14,811 crore through initial public offerings (IPOs) in 2024, marking the highest amount since...
The medical device sector in India is recognized as a sunrise sector because of its immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities, as...
Lipocine Inc., a biopharmaceutical company utilizing its own technology platform to enhance therapeutics via efficient oral delivery, reported that the US Food and Drug Administration (FDA) has awarded Fast Track Designation to LPCN 1148 for...
India's pharmaceutical sector, ranked as the third largest in the world by volume, was valued at $50 billion in the fiscal year 2023-24, as per Union Minister of State for Chemicals and Fertilizers Anupriya Patel. The domestic consumption value of...
The secondary packaging market for biologics CDMO is undergoing considerable expansion owing to the rising incidence of chronic illnesses globally. As chronic diseases become more common, the necessity for novel therapies and precision medicine...
Merck announced that the US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for clesrovimab (MK-1654), the company's experimental long-acting monoclonal antibody aimed at safeguarding infants from...
Supriya Lifescience's new plant is anticipated to improve production capabilities, aiding its expansion in the competitive pharmaceutical sector. Pharma shares experienced a 6 percent rise after the launch of a modern E-Production Block in...
The market for AI in clinical trials is fueled by the significant rate of clinical trial failures, the growing demand for predicting drug pharmacokinetics, pharmacodynamics, and toxicity management. The worldwide market for artificial intelligence...
, CDSCO.jpg)
